Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Chemotherapy versus personalized therapy for EGFR mutant lung adenocarcinoma resistance to EGFR-tyrosine kinase inhibitors: a retrospective dual-center study
PaperCitations, authors & open-access status
Chemotherapy versus personalized therapy for EGFR mutant lung adenocarcinoma resistance to EGFR-tyrosine kinase inhibitors: a retrospective dual-center study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2 citations, 2024 year and gold oa status.
2
Citations
2024
Year
gold
OA Status